This is the protocol for a review and there is no abstract. The objectives are as follows:
B A C K G R O U N D Description of the condition
Central venous catheters (CVC) are essential devices in the care of sick individuals. A CVC provides a relatively secure access for administering intravenous medications, fluids and parenteral nutrition. It is estimated that, annually, five million and 200,000 CVCs are used in the USA and UK, respectively (Worthington 2005). One of the major problems associated with the use of CVCs is catheter-related infections, which have been shown to cause significant morbidity and mortality associated with considerable costs to the healthcare system (CDC 2011; Cicalini 2004) . It is estimated that in the USA approximately 80,000 cases of CVC-associated blood stream infections (BSIs) occur in intensive care units (ICUs) every year, with a mortality rate of up to 35% and estimated associated healthcare costs ranging from US$296 million to US$2.3 billion (CDC 2011). These estimates, however, are based mainly on adult data. CVCs are frequently placed in newborn infants in the neonatal intensive care unit (NICU). Infants in the NICU represent a distinct group of individuals who are particularly at risk of infections due to their compromised skin barrier and immature immune system (Ygberg 2012). The presence of a CVC represents a significant risk factor for catheter-related infection in newborn infants, in particular catheter-related BSI (CRBSI) (Chien 2002; Couto 
